Sternal Closure Systems Market Summary
As per Market Research Future Analysis, the Sternal Closure Systems Market was valued at 2.12 USD Billion in 2024 and is projected to grow to 3.62 USD Billion by 2034, with a CAGR of 5.52% from 2025 to 2034. The market growth is primarily driven by the increasing number of older adults undergoing open-heart surgeries, particularly through median sternotomy, which remains the most common method for cardiac exposure. Key developments include Abyrx's FDA approval for MONTAGE bone putty in cardiothoracic surgery and the introduction of innovative sternal closure devices by various companies.
Key Market Trends & Highlights
The Sternal Closure Systems market is witnessing significant growth due to various factors.
- The market is expected to grow from 2.23 USD Billion in 2025 to 3.62 USD Billion by 2034.
- Median sternotomy procedures are projected to dominate the market, being the fastest-growing segment.
- The aging population is increasing the prevalence of cardiovascular diseases, driving demand for sternal closure systems.
- Europe accounted for 45.80% of the market share in 2022, indicating strong regional demand.
Market Size & Forecast
2024 Market Size | USD 2.12 Billion |
2025 Market Size | USD 2.23 Billion |
2034 Market Size | USD 3.62 Billion |
CAGR (2025-2034) | 5.52% |
Major Players
Key players include Depuy Synthes, Zimmer Biomet Holdings, Orthofix International N.V., A&E Medical, Kinamed Incorporated, Abyrx.